Who Owns Definium Therapeutics Stock?
NASDAQ: DFTXHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 88.51%
- Held by insiders
- 2.57%
- Institutional holders
- 465
- Institutions 88.5%
- Insiders 2.6%
- Public and other 8.9%
Who owns Definium Therapeutics stock?
Institutional investors own about 88.5% of Definium Therapeutics's shares, spread across 465 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.57% of DFTX.
The largest institutional holders are Blackrock Inc. (8.36%), Avoro Capital Advisors LLC (5.35%) and Driehaus Capital Management, LLC (5.09%). Together, the top 10 institutions control 41.2% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their DFTX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DFTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 11.23M | 8.36% | +32.5% |
| Avoro Capital Advisors LLC | 7.19M | 5.35% | +43.8% |
| Driehaus Capital Management, LLC | 6.85M | 5.09% | +15.8% |
| Jupiter Topco LLC | 5.62M | 4.18% | +100.0% |
| Capital World Investors | 5.37M | 3.99% | +100.0% |
| FMR, LLC | 4.75M | 3.54% | +162.7% |
| Price (T.Rowe) Associates Inc | 4.65M | 3.46% | +6545.7% |
| Geode Capital Management, LLC | 3.64M | 2.71% | +46.1% |
| State Street Corporation | 3.07M | 2.28% | +24.0% |
| Capital International Investors | 2.96M | 2.21% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DFTX
| Fund | Shares | % Held |
|---|---|---|
| SmallCap World Fund Inc | 7.69M | 5.72% |
| iShares Trust-iShares Russell 2000 ETF | 3.33M | 2.48% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.49M | 1.11% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.42M | 1.06% |
| T. Rowe Price Health Sciences Fund, Inc. | 1.29M | 0.96% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.22M | 0.91% |
| T. Rowe Price New Horizons Fund, Inc. | 1.14M | 0.85% |
| iShares Trust-iShares Biotechnology ETF | 953.25K | 0.71% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 779.40K | 0.58% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 740.60K | 0.55% |
Frequently asked questions
Who is the largest shareholder of Definium Therapeutics?
Blackrock Inc. is the largest institutional shareholder of DFTX, owning 8.36% of shares outstanding (11.23M shares) as of its latest 13F filing.
What percentage of Definium Therapeutics is owned by institutions?
Institutions own about 88.5% of DFTX shares and 90.8% of the public float.
How much of Definium Therapeutics do insiders own?
Insiders, such as officers and directors, own about 2.57% of DFTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.